Lunai Bioworks LNAI
NASDAQ LNAI
$1.77 -0.07 (-3.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) Gross Margin (2013 - 2026)

Updated

Lunai Bioworks (LNAI) posted Gross Margin of 100.00% for fiscal Q3 2026 (quarter ended Mar 31, 2026).

Analysis

Lunai Bioworks (LNAI) Gross Margin (2013 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Gross Margin at Lunai Bioworks was -360.55%; for FY2016 (ended Jun 30, 2016), it was 87.67%.

  • Annual Gross Margin shows a four-year change of +90.18 percentage points (FY2012 to FY2016).
  • In prior fiscal years, Lunai Bioworks' Gross Margin was 87.67% in FY2015, -233.55% in FY2013 (-231.04 pp) and -2.51% in FY2012.
  • The fiscal Q3 2026 figure stands as the lowest quarterly Gross Margin since fiscal Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Lunai Bioworks 5.81 Mn 1.06 Mn 20,942.00 100.00%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 100.00%
Dec 31, 2015 87.67%
Sep 30, 2013 -1,651.14%
Mar 31, 2013 51.33%
API Access

Lunai Bioworks Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=LNAI&period=max&api_key=YOUR_API_KEY